This article reviews the production characteristics and perceptual cues of intervocalic consonants as a background for acoustic studies of consonant perception in fluent speech. Data show that in conversation intervocalic consonants occur much more commonly than consonants in initial or final position; all phonetic features are strongly represented. Production characteristics of intervocalic consonants are seen to depend on the tempo and rhythmic conditions of the syllables of which they are components. At a moderate tempo, consonants in syllable-final position combine with the onset consonant of the following syllable. This affects durational characteristics and may be explained by higher energy efficiency of CV units in production. Phonological phenomena are related to the shifts in syllable position and the temporal compensations of intervocalic consonant production. Studies of consonant perception in fluent context have dealt with tempo of utterance, position in word, and rhythmic pattern, as well as phonemic context. Major phenomena are effects of coarticulation, invariance in consonant perception, and cue interaction and masking. Much evidence suggests a dominance of the perceptual cues in the CV portion of VCCV and VCV sequences. We suggest that exploration of perception variables that affect consonants in fluent context would be expedited by reorienting experimental procedures to employ listener adjustment of stimuli, instead of the traditional phoneme identification and discrimination procedures with large sets of constant stimuli. Most of the relevant literature deals with stop consonants. Lateral, rhotic, and nasal consonants also deserve intensive study because of their very frequent occurrence. Theoretical issues of phoneme perceptual invariance and motor vs. auditory theory of perception are discussed in relation to proposed experiments which vary syllable tempo and stress pattern.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.